Loading clinical trials...
Loading clinical trials...
Induced Pluripotent Stem (iPS) Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
Conditions
Interventions
A-T iPS cell line
Carrier patients iPS cell line
Locations
1
United States
SKCCC at Johns Hopkins
Baltimore, Maryland, United States
Start Date
February 3, 2015
Primary Completion Date
July 5, 2018
Completion Date
July 5, 2018
Last Updated
March 19, 2019
Lead Sponsor
Johns Hopkins University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions